8.790USD-4.66%Mkt Cap: 61.82M $P/E: —1d ago
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical syst…
Industry Peers
Drug Manufacturers - General$1.04TUSDP/E 41.6
$601.73BUSDP/E 29.0
$449.42BUSDP/E 124.1
$305.83BUSDP/E 21.0
$315.22BUSDP/E 36.0
$272.16BUSDP/E 21.8
$268.42BUSDP/E 21.8
$243.51BUSDP/E 25.4
$216.37BUSDP/E 12.3
$212.87BUSDP/E 25.1
$200.54BUSDP/E 25.9
$169.23BUSDP/E 18.5
$143.28BUSDP/E 19.2
$123.57BUSDP/E 16.9
$100.10BUSDP/E 19.4
$85.16BUSDP/E 13.8
$50.96BUSD
$30.84BUSDP/E 22.4
MRV
Marvell Technology, Inc.$20.08BUSDP/E 7.4
$11.37BUSDP/E 22.7
$10.53BUSDP/E 18.3
$10.47BUSDP/E 18.2
$6.76BUSDP/E 15.0
$3.54BUSDP/E 14.5
$2.97BUSDP/E 18.1
$39.24MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FR0000140022
SANOFITP29OCT49—
FLXN
Horizon Flexible Income ETF—P/E 27.0
CELG-RI
Bristol-Myers Squibb Company Ce—
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap61.82M $
Enterprise Value159.97M $
Revenue (TTM)33.86M $
Gross Profit19.65M $
Net Income (TTM)-358.73M $
Revenue/Share3.432 USD
Last Price8.790 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees34
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.04
PEG—
EV/EBITDA-0.59
EV/Revenue4.72
P/S1.83
P/B-0.25
EPS (TTM)-40.50
EPS (Forward)0.73
52W Range
4.20015% of range34.27
52W High34.27 USD
52W Low4.200 USD
Profitability
Gross Margin64.97%
Oper. Margin-373.49%
EBITDA Margin0.00%
Profit Margin-1185.78%
ROE172.65%
ROA-98.29%
Growth
Revenue Growth72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.82M $
CapEx (TTM)733.00K $
FCF Margin17.68%
FCF Yield9.68%
Net Debt103.00M $
Net Debt/EBITDA-0.38
Balance Sheet
Debt/Equity-0.60
Current Ratio0.08
Quick Ratio0.07
Book Value/Sh-35.4360 USD
Cash/Share0.4780 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1606:1000
Split DateJun 16, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.7.03M
Float5.69M
Insiders11.67%
Institutions13.10%
Short Interest
Short Ratio2.0d
Short % Float2.96%
Short % Out.2.33%
Shares Short163.99K
Short (prev mo.)229.01K
Technical
SMA 505.990 (+46.7%)
SMA 2007.338 (+19.8%)
Beta1.73
S&P 52W Chg20.25%
Avg Vol (30d)159.32K
Avg Vol (10d)329.96K
Technical Indicators
RSI (14)55.1
MACD0.4852
MACD Signal0.3805
MACD Hist.+0.1047
BB Upper10.19 USD
BB Middle7.964 USD
BB Lower5.736 USD
BB Width55.95%
ATR (14)1.023 USD
Vol Ratio (20d)0.15x